bpc 157 pharmacy BIG NEWS FOR Today, the FDA's Compounding Advisory Committee voted 8 to 6 to recommend adding BPC 157 to the list of substances that may be eligible for pharmacy smartmedicine #bpc157 #fda #evidencebasedmedicine #orthopedics

The genetic test reveals predispositions in nutrient absorption and energy metabolism pathwaysnot exact B12 response or dose prediction

While no studies have specifically examined this in tirzepatide users, the biological plausibility is sound

Strictly no compromises

Stacked Protocol (AOD + MOTS-c) Dose: 0.5 mg AOD + 10 mg MOTS-c (= 20 clicks) Duration: 4 weeks Frequency: Daily Cycle Interval: Optional 2-week pause Goal / Description: 2 weeks off, then repeat or switch to MOTS-c only maintenance Possible Side Effects AOD-9604 is generally well-tolerated in research settings

You'll earn on You'll earn bonus points on your special day